Human natural killer cells: their origin, receptors and function
The term of "natural killer" (NK) cells was originally assigned on a merely functional basis to lymphoid cells capable of lysing certain tumors in the absence of prior stimulation. However, both their origin and the molecular mechanism(s) involved in their function remained a mystery for m...
Gespeichert in:
Veröffentlicht in: | European journal of immunology 2002-05, Vol.32 (5), p.1205-1211 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1211 |
---|---|
container_issue | 5 |
container_start_page | 1205 |
container_title | European journal of immunology |
container_volume | 32 |
creator | Moretta, Lorenzo Bottino, Cristina Pende, Daniela Mingari, Maria Cristina Biassoni, Roberto Moretta, Alessandro |
description | The term of "natural killer" (NK) cells was originally assigned on a merely functional basis to lymphoid cells capable of lysing certain tumors in the absence of prior stimulation. However, both their origin and the molecular mechanism(s) involved in their function remained a mystery for many years 1. Regarding their origin, clear evidence has now been provided both inmouse and in man that NK and T cells may derive from a common precursor 2–5. Thus, mature NK cells can be obtained in vitro from CD34+ cells isolated from umbilical cord blood, bone marrow (BM) and even human thymus 6 when cultured in the presence of appropriate feeder cells or IL‐15. The molecular mechanism allowing NK cells to discriminate between normal and tumor cells, predicted by the "missing self hypothesis" 7, has been clarified only in recent years. Thus, NK cells recognize MHC class I molecules through surface receptors delivering signals that inhibit, rather than activate, NK cells. As a consequence, NK cells lyse target cells that have lost (or express insufficient amounts of) MHC class I molecules, as frequently occurs in tumors and in cells infected by certain viruses. |
doi_str_mv | 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71712930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71712930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4715-f8526e11236ae9c39b7748bccdf371fa16a215f91302a539bdf4eb7c18ebf8713</originalsourceid><addsrcrecordid>eNqVkVtL7DAUhYMc0fHyF6RPcgQ7ZifNpBlFlPE2oMyDCsenTZpJtNppx6RF_Pe2zBx9EvEp2cmXtcJahBwC7QOl7AAEgziBBP6ydqRij7OhOIJ2Nxyejs_i8c3NfTcd8z7tjyaHLH5YIb3PV39Ij1JIYqZSuk42QnimlKqBUGtkHUClkFLZIydXzUyXUanrxusiesmLwvrI2KIIw6h-srmPKp8_5uV-5K2x87ryIdLlNHJNaeq8KrfIqtNFsNvLdZPcX5zfja7i68nleHR6HZtEgohdKtjAAjA-0FYZrjIpkzQzZuq4BKdhoBkIp4BTpkV7PXWJzaSB1GYulcA3ye5Cd-6r18aGGmd56P6pS1s1ASVIYIrTH0FIuRIJEy14uwCNr0Lw1uHc5zPt3xEodg1glyV2WeKiAeQMBXaZI7YN4P8GkCPF0QQZPrSqO0v7JpvZ6ZfmMvIW-LcA3vLCvv_G8xvLzzP-ARpnnvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18395425</pqid></control><display><type>article</type><title>Human natural killer cells: their origin, receptors and function</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Moretta, Lorenzo ; Bottino, Cristina ; Pende, Daniela ; Mingari, Maria Cristina ; Biassoni, Roberto ; Moretta, Alessandro</creator><creatorcontrib>Moretta, Lorenzo ; Bottino, Cristina ; Pende, Daniela ; Mingari, Maria Cristina ; Biassoni, Roberto ; Moretta, Alessandro</creatorcontrib><description>The term of "natural killer" (NK) cells was originally assigned on a merely functional basis to lymphoid cells capable of lysing certain tumors in the absence of prior stimulation. However, both their origin and the molecular mechanism(s) involved in their function remained a mystery for many years 1. Regarding their origin, clear evidence has now been provided both inmouse and in man that NK and T cells may derive from a common precursor 2–5. Thus, mature NK cells can be obtained in vitro from CD34+ cells isolated from umbilical cord blood, bone marrow (BM) and even human thymus 6 when cultured in the presence of appropriate feeder cells or IL‐15. The molecular mechanism allowing NK cells to discriminate between normal and tumor cells, predicted by the "missing self hypothesis" 7, has been clarified only in recent years. Thus, NK cells recognize MHC class I molecules through surface receptors delivering signals that inhibit, rather than activate, NK cells. As a consequence, NK cells lyse target cells that have lost (or express insufficient amounts of) MHC class I molecules, as frequently occurs in tumors and in cells infected by certain viruses.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y</identifier><identifier>PMID: 11981807</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Adaptation, Physiological ; Animals ; Biological Evolution ; Bone Marrow Transplantation ; Cell Differentiation ; Cytotoxicity, Immunologic ; Histocompatibility Antigens Class I - metabolism ; HLA Antigens - metabolism ; HLA-E Antigens ; Humans ; Killer Cells, Natural - cytology ; Killer Cells, Natural - immunology ; Killer Cells, Natural - physiology ; KIR ; Ligands ; MHC class I‐specific inhibitory receptor ; Mice ; Natural cytotoxicity ; Neoplasms - immunology ; NK cell ; NK coreceptor ; Receptors, Immunologic - metabolism</subject><ispartof>European journal of immunology, 2002-05, Vol.32 (5), p.1205-1211</ispartof><rights>WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1521-4141%28200205%2932%3A5%3C1205%3A%3AAID-IMMU1205%3E3.0.CO%3B2-Y$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1521-4141%28200205%2932%3A5%3C1205%3A%3AAID-IMMU1205%3E3.0.CO%3B2-Y$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46387,46811</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11981807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moretta, Lorenzo</creatorcontrib><creatorcontrib>Bottino, Cristina</creatorcontrib><creatorcontrib>Pende, Daniela</creatorcontrib><creatorcontrib>Mingari, Maria Cristina</creatorcontrib><creatorcontrib>Biassoni, Roberto</creatorcontrib><creatorcontrib>Moretta, Alessandro</creatorcontrib><title>Human natural killer cells: their origin, receptors and function</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>The term of "natural killer" (NK) cells was originally assigned on a merely functional basis to lymphoid cells capable of lysing certain tumors in the absence of prior stimulation. However, both their origin and the molecular mechanism(s) involved in their function remained a mystery for many years 1. Regarding their origin, clear evidence has now been provided both inmouse and in man that NK and T cells may derive from a common precursor 2–5. Thus, mature NK cells can be obtained in vitro from CD34+ cells isolated from umbilical cord blood, bone marrow (BM) and even human thymus 6 when cultured in the presence of appropriate feeder cells or IL‐15. The molecular mechanism allowing NK cells to discriminate between normal and tumor cells, predicted by the "missing self hypothesis" 7, has been clarified only in recent years. Thus, NK cells recognize MHC class I molecules through surface receptors delivering signals that inhibit, rather than activate, NK cells. As a consequence, NK cells lyse target cells that have lost (or express insufficient amounts of) MHC class I molecules, as frequently occurs in tumors and in cells infected by certain viruses.</description><subject>Adaptation, Physiological</subject><subject>Animals</subject><subject>Biological Evolution</subject><subject>Bone Marrow Transplantation</subject><subject>Cell Differentiation</subject><subject>Cytotoxicity, Immunologic</subject><subject>Histocompatibility Antigens Class I - metabolism</subject><subject>HLA Antigens - metabolism</subject><subject>HLA-E Antigens</subject><subject>Humans</subject><subject>Killer Cells, Natural - cytology</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - physiology</subject><subject>KIR</subject><subject>Ligands</subject><subject>MHC class I‐specific inhibitory receptor</subject><subject>Mice</subject><subject>Natural cytotoxicity</subject><subject>Neoplasms - immunology</subject><subject>NK cell</subject><subject>NK coreceptor</subject><subject>Receptors, Immunologic - metabolism</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkVtL7DAUhYMc0fHyF6RPcgQ7ZifNpBlFlPE2oMyDCsenTZpJtNppx6RF_Pe2zBx9EvEp2cmXtcJahBwC7QOl7AAEgziBBP6ydqRij7OhOIJ2Nxyejs_i8c3NfTcd8z7tjyaHLH5YIb3PV39Ij1JIYqZSuk42QnimlKqBUGtkHUClkFLZIydXzUyXUanrxusiesmLwvrI2KIIw6h-srmPKp8_5uV-5K2x87ryIdLlNHJNaeq8KrfIqtNFsNvLdZPcX5zfja7i68nleHR6HZtEgohdKtjAAjA-0FYZrjIpkzQzZuq4BKdhoBkIp4BTpkV7PXWJzaSB1GYulcA3ye5Cd-6r18aGGmd56P6pS1s1ASVIYIrTH0FIuRIJEy14uwCNr0Lw1uHc5zPt3xEodg1glyV2WeKiAeQMBXaZI7YN4P8GkCPF0QQZPrSqO0v7JpvZ6ZfmMvIW-LcA3vLCvv_G8xvLzzP-ARpnnvA</recordid><startdate>200205</startdate><enddate>200205</enddate><creator>Moretta, Lorenzo</creator><creator>Bottino, Cristina</creator><creator>Pende, Daniela</creator><creator>Mingari, Maria Cristina</creator><creator>Biassoni, Roberto</creator><creator>Moretta, Alessandro</creator><general>WILEY‐VCH Verlag GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200205</creationdate><title>Human natural killer cells: their origin, receptors and function</title><author>Moretta, Lorenzo ; Bottino, Cristina ; Pende, Daniela ; Mingari, Maria Cristina ; Biassoni, Roberto ; Moretta, Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4715-f8526e11236ae9c39b7748bccdf371fa16a215f91302a539bdf4eb7c18ebf8713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adaptation, Physiological</topic><topic>Animals</topic><topic>Biological Evolution</topic><topic>Bone Marrow Transplantation</topic><topic>Cell Differentiation</topic><topic>Cytotoxicity, Immunologic</topic><topic>Histocompatibility Antigens Class I - metabolism</topic><topic>HLA Antigens - metabolism</topic><topic>HLA-E Antigens</topic><topic>Humans</topic><topic>Killer Cells, Natural - cytology</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - physiology</topic><topic>KIR</topic><topic>Ligands</topic><topic>MHC class I‐specific inhibitory receptor</topic><topic>Mice</topic><topic>Natural cytotoxicity</topic><topic>Neoplasms - immunology</topic><topic>NK cell</topic><topic>NK coreceptor</topic><topic>Receptors, Immunologic - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moretta, Lorenzo</creatorcontrib><creatorcontrib>Bottino, Cristina</creatorcontrib><creatorcontrib>Pende, Daniela</creatorcontrib><creatorcontrib>Mingari, Maria Cristina</creatorcontrib><creatorcontrib>Biassoni, Roberto</creatorcontrib><creatorcontrib>Moretta, Alessandro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moretta, Lorenzo</au><au>Bottino, Cristina</au><au>Pende, Daniela</au><au>Mingari, Maria Cristina</au><au>Biassoni, Roberto</au><au>Moretta, Alessandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human natural killer cells: their origin, receptors and function</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2002-05</date><risdate>2002</risdate><volume>32</volume><issue>5</issue><spage>1205</spage><epage>1211</epage><pages>1205-1211</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>The term of "natural killer" (NK) cells was originally assigned on a merely functional basis to lymphoid cells capable of lysing certain tumors in the absence of prior stimulation. However, both their origin and the molecular mechanism(s) involved in their function remained a mystery for many years 1. Regarding their origin, clear evidence has now been provided both inmouse and in man that NK and T cells may derive from a common precursor 2–5. Thus, mature NK cells can be obtained in vitro from CD34+ cells isolated from umbilical cord blood, bone marrow (BM) and even human thymus 6 when cultured in the presence of appropriate feeder cells or IL‐15. The molecular mechanism allowing NK cells to discriminate between normal and tumor cells, predicted by the "missing self hypothesis" 7, has been clarified only in recent years. Thus, NK cells recognize MHC class I molecules through surface receptors delivering signals that inhibit, rather than activate, NK cells. As a consequence, NK cells lyse target cells that have lost (or express insufficient amounts of) MHC class I molecules, as frequently occurs in tumors and in cells infected by certain viruses.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>11981807</pmid><doi>10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 2002-05, Vol.32 (5), p.1205-1211 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_71712930 |
source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Adaptation, Physiological Animals Biological Evolution Bone Marrow Transplantation Cell Differentiation Cytotoxicity, Immunologic Histocompatibility Antigens Class I - metabolism HLA Antigens - metabolism HLA-E Antigens Humans Killer Cells, Natural - cytology Killer Cells, Natural - immunology Killer Cells, Natural - physiology KIR Ligands MHC class I‐specific inhibitory receptor Mice Natural cytotoxicity Neoplasms - immunology NK cell NK coreceptor Receptors, Immunologic - metabolism |
title | Human natural killer cells: their origin, receptors and function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A03%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20natural%20killer%20cells:%20their%20origin,%20receptors%20and%20function&rft.jtitle=European%20journal%20of%20immunology&rft.au=Moretta,%20Lorenzo&rft.date=2002-05&rft.volume=32&rft.issue=5&rft.spage=1205&rft.epage=1211&rft.pages=1205-1211&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/1521-4141(200205)32:5%3C1205::AID-IMMU1205%3E3.0.CO;2-Y&rft_dat=%3Cproquest_cross%3E71712930%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18395425&rft_id=info:pmid/11981807&rfr_iscdi=true |